Baxter Internationalvs.Becton Dickinson
BAX vs BDX · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
Becton Dickinson is about 3.6× larger than Baxter International by market cap; year to date, Baxter International leads (+38.6% vs +25.0%).
Side by side
| BAX | BDX | |
|---|---|---|
| Market cap | $14B | $50.1B |
| Price | $26.29 | $189.78 |
| Today | −0.8% | −0.5% |
| Return YTD | +38.6% | +25.0% |
| Return 1Y | +7.9% | +21.5% |
| P/E | — | 53.2 |
| P/S | 1.2 | 2.4 |
| P/B | 2.3 | 2.1 |
Data as of 2026-08-26 · updates daily after U.S. close
The two companies
Baxter InternationalBAX
Infusion pumps and the fluids that run through them are the anchor. Baxter also supplies dialysis therapy and products for surgery and acute care.
Full BAX profile →Becton DickinsonBDX
Syringes and needles sit at the recognisable end of the range. Becton Dickinson's portfolio is broad, spanning medical consumables alongside diagnostic systems and drug delivery equipment.
Full BDX profile →More BAX & BDX comparisons
Other head-to-heads in the Medtech & devices segment.
See where BAX and BDX sit in the full Medicine, pharma & life science map: every segment from suppliers to end markets.Open the Life science value chain →